Metastasis: a therapeutic target for cancer

PS Steeg, D Theodorescu - Nature clinical practice Oncology, 2008 - nature.com
Metastasis remains the major driver of mortality in patients with cancer. Our growing body of
knowledge regarding this process provides the basis for the development of molecularly …

Grb2 signaling in cell motility and cancer

A Giubellino, TR Burke, DP Bottaro - Expert opinion on therapeutic …, 2008 - Taylor & Francis
Background: Metastasis is the primary cause of death in most human cancers, and
understanding the molecular mechanisms underpinning this multistep process is …

NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization

J Su, G Wu, Y Ye, J Zhang, L Zeng, X Huang, Y Zheng… - Oncogene, 2021 - nature.com
Methylcytosine (m5C) is a posttranscriptional RNA modification participating in many critical
bioprocesses, but its functions in human cancer remain unclear. Here, by detecting the …

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration

K Zarrabi, A Dufour, J Li, C Kuscu… - Journal of Biological …, 2011 - ASBMB
Matrix metalloproteinases (MMPs) have been shown to be key players in both extracellular
matrix remodeling and cell migration during cancer metastasis. MMP-14, a membrane …

Progress towards the development of SH2 domain inhibitors

D Kraskouskaya, E Duodu, CC Arpin… - Chemical Society …, 2013 - pubs.rsc.org
Src homology 2 (SH2) domains are 100 amino acid modular units, which recognize and
bind to tyrosyl-phosphorylated peptide sequences on their target proteins, and thereby …

MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines

MK Muniyappa, P Dowling, M Henry, P Meleady… - European journal of …, 2009 - Elsevier
In this study we have identified a functional role for miR-29a in cancer cell invasion and
proliferation. MiRNA expression profiling of human NSCLC cell lines indicated that miR-29a …

A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model

S Rahim, T Minas, SH Hong, S Justvig, H Çelik… - PLoS …, 2014 - journals.plos.org
Background The erythroblastosis virus E26 transforming sequences (ETS) family of
transcription factors consists of a highly conserved group of genes that play important roles …

Targeting SH2 domains in breast cancer

P Morlacchi, FM Robertson, J Klostergaard… - Future medicinal …, 2014 - Taylor & Francis
Breast cancer is among the most commonly diagnosed cancer types in women worldwide
and is the second leading cause of cancer-related disease in the USA. SH2 domains recruit …

Targeting the HGF‐cMET axis in hepatocellular carcinoma

NK Venepalli, L Goff - International journal of hepatology, 2013 - Wiley Online Library
Under normal physiological conditions, the hepatocyte growth factor (HGF) and its receptor,
the MET transmembrane tyrosine kinase (cMET), are involved in embryogenesis …

Targeting the Met signaling pathway in renal cancer

A Giubellino, WM Linehan… - Expert review of anticancer …, 2009 - Taylor & Francis
Renal cell carcinoma (RCC), the most common form of kidney cancer, accounts for 3% of all
adult malignancies and its incidence has significantly increased over the last 20 years. RCC …